Midodrine: A role in the management of neurocardiogenic syncope

Heart

Volumn 79, Issue 1, 1998, Pages 45-49

  Ward, C R ^a   Gray, J C ^a   Gilroy, J J ^a   Kenny, R A ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Head up tilt test; Midodrine; Neurocardiogenic syncope

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; MIDODRINE;

ADULT; ARTICLE; BLOOD PRESSURE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEAD TILTING; HEART RATE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; SYNCOPE;

EID: 0031958883     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.79.1.45     Document Type: Article

References (36)

1. Abi-Samra F, Malony JD, Fouad-Tarazi FM, et al. The usefulness of head-up tilt testing and haemodynamic investigation in the work up of syncope of unknown origin. PACE 1988;11:1202-14.
2. Hainsworth R, Al-Shamma YMH. Cardiovascular responses to upright tilting in healthy subjects. Clin Sci (Colch) 1988;74:17-22.
3. van Lieshout JJ, Wieling W, Karemaker JM, et al. The vasovagal response [editorial]. Clin Sci (Colch) 1991;81: 575-86.
4. Grubb BP, Kosinski D. Current trends in etiology, diagnosis, and management of neurocardiogenic syncope. Curr Opin Cardiol 1996;11:32-41
5. Hargreaves AD, Boon NA. Head-up tilt testing: the balance of evidence. Br Heart J 1994;72:216-17.
6. Kenny RA, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986;i:1352-4.
7. Benditt DG, Remole S, Balin S, et al. Tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope: rationale and proposed protocols. PACE 1991;14: 1528-37.
8. Fitzpatrick A, Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989;i:658-69.
9. Raviele A, Gasparini G, Menozzi C, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995;76:267-72.
10. McIntosh S, Lawson J, da Costa D, et al. Use of sublingual glyceryl trinitrate during head-up tilt: a provocative test for reproduction of neurocardiogenic symptoms in unexplained syncope. Cardiology in the Elderly 1996;4:33-7.
11. Almquist A, Goldenburg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-51.
12. Grubb BP, Temesy-Amos P, Moore J, et al. Head-upright tilt table testing in evaluation and management of the maliganant vasovagal syndrome. Am J Cardiol 1992;69:904-8.
13. Ward CR, Kenny RA. Observations on midodrine in a case of vasodepressor neurogenic syncope. Clin Auton Res 1995; 5:257-60.
14. Petersen MEV, Williams TR, Sutton R. A comparison of non-invasive continuous finger blood pressure measurement (Finapres) with intra-arterial pressure during prolonged head-up tilt. Eur Heart J 1995;16:1647-54.
15. Imholz BPM, Settels JJ, van den Meiracker AH, et al. Non-invasive beat to beat finger blood pressure measurement during orthostatic stress compared to intraarterial pressure. Cardiovasc Res 1990;24:214-21.
16. Kubicek WG, Karnegis JM, Patterson RP, et al. Development and evaluation of an impedance cardiac output system. Aerospace Medicine 1966;37:1208-12.
17. Kubicek WG, Karnegis JM, Patterson RP, et al. Impedance cardiography as a non-invasive method to monitor cardiac function and other parameters of the cardiovascular system. Ann NY Acad Sci 1970;170:724-32.
18. McHorney CA, Ware JE, Raczek AE. The MOS 36-ItemShort Form Health Survey (SF-36) II. Psychometric and clinic al tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
19. Hargreaves A, Muir A. Lack of variation in venous tone potentiates vasovagal syncope. Br Heart J 1992;67:486-90.
20. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. JAm Coll Cardiol 1995;25:65-9.
21. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 1994;97:78-88.
22. Come PC, Pitt B. Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 1976;54:624-8.
23. Morillo CA, Leitch JW, Yee R, et al. A placebo controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-8.
24. Fitzpatrick A, Ahmed R, Williams S, et al. A randomised trial of medical therapy in "malignant vasovagal syndrome" or "neurally-mediated bradycardia/hypotension syndrome". European Journal of Cardiac Pacing and Electrophysiology 1991;2:99-102.
25. Goldstein DS, Spannarkel M, Pitterman A, et al. Circulatory control mechanisms in vasodepressor syncope. Am Heart J 1982;104:1071-5.
26. Sra JS, Anderson AJ, Sheikh SH, et al. Unexplained syncope evaluated by electrophysiological studies and head-up tilt testing. Ann Intern Med 1991;114:1013-19.
27. Sutton R, Peterson M, Brignole M, et al. Proposed classification for tilt-induced vasovagal syncope. European Journal of Cardiac Pacing and Electrophysiology 1992;2:180-3.
28. Milstein S, Buetitikofer J, Dunnigan A, et al. Usefulness of disopyramide for prevention of upright tilt induced hypotension-bradycardia. Am J Cardiol 1990;65:1339-44.
29. Ferguson DW, Thomes MD, Mark AL. Effects of propranolol on reflex vascular responses to orthostatic stress in humans: role of baroreceptors. Circulation 1983;67:802-7.
30. Natale A, Sra J, Dhala A, et al. Efficacy of different treatment strategies for neurocardiogenic syncope. PACE 1995;18: 655-62.
31. Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trail of acute and long term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992;70:339-42.
32. Jankovic J, Hiner BC, Brown DC. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993;95:38-48.
33. Kaufmann H, Brannan T, Krakoff L, et al. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 1988;38:951-6.
34. Erhringer H. Studies on the peripheral haemodynamics in man after intravenous infusion of a small dose of di-1-(2′,5′-dimethoxyphenyl)-2-glycinamido-ethanol-(1)- hydrochloride. Int J Clin Pharmacol Ther Toxicol 1971;4: 415-20.
35. Piwinski SE, Jankovic J, McElligot MA. A comparison of post space night orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha-agonist for these conditions. J Clin Pharmacol 1994; 34:466-71.
36. Linzer M, Pontinen M, Gold D. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 1991;44:1037-43.